Guardant Health (GH) Cash from Investing Activities (2017 - 2026)

Guardant Health (GH) has 10 years of Cash from Investing Activities data on file, last reported at $699.4 million in Q1 2026.

• Quarterly Cash from Investing Activities rose 130.93% year-over-year to $699.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$230.6 million (down 1809.77% YoY) and the FY2025 annual result came in at -$627.2 million, down 140.02% from the prior year.
• Cash from Investing Activities rose to $699.4 million in Q1 2026 per GH's latest filing, from -$905.1 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $699.4 million in Q1 2026, with the low at -$905.1 million in Q4 2025.
• Average Cash from Investing Activities over 5 years is $47.1 million, with a median of $28.1 million recorded in 2024.
• The widest YoY moves for Cash from Investing Activities: up 979.11% in 2025, down 8695.13% in 2025.
• Guardant Health's Cash from Investing Activities stood at $70.6 million in 2022, then soared by 839.38% to $663.5 million in 2023, then tumbled by 98.41% to $10.5 million in 2024, then sank by 8695.13% to -$905.1 million in 2025, then surged by 177.28% to $699.4 million in 2026.
• Business Quant data shows GH's Cash from Investing Activities at $699.4 million in Q1 2026, -$905.1 million in Q4 2025, and -$14.4 million in Q3 2025.